Hepion Pharmaceuticals Inc (NASDAQ:HEPA)

Delayed Data
As of Jun 06
 +0.47 / +4.10%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Hepion Pharmaceuticals Inc have a median target of 30.00, with a high estimate of 74.00 and a low estimate of 28.00. The median estimate represents a +152.10% increase from the last price of 11.90.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Hepion Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 30

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 4.50%
Growthannually -5.12%


Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.